Literature DB >> 23862738

Impact of blood glucose variability on carotid artery intima media thickness and distensibility in type 1 diabetes mellitus.

Francesca Cesana1, Cristina Giannattasio, Stefano Nava, Francesco Soriano, Gianmaria Brambilla, Matteo Baroni, Paolo Meani, Marisa Varrenti, Felice Paleari, Pierluigi Gamba, Rita Facchetti, Marta Alloni, Guido Grassi, Giuseppe Mancia.   

Abstract

AIMS: Diabetes mellitus is characterized by structural and functional alterations of the large- and medium-size arteries. Whether blood glucose variability, i.e. the glycemic oscillations occurring during the 24-h period, represents a risk factor for vascular alterations additional to and independent on HbA1c in type 1 diabetes mellitus is still undefined. The present study was carried out with the aim at investigating the impact of different measures of blood glucose variability on arterial structure and function. We studied 17 non-complicated type 1 diabetic patients (11 males, six females) with an age of 40.8 ± 7.6 years (mean ± SD). In each patient, 24-h glucose profile was obtained by continuous glucose monitoring system and glucose variability was expressed as mean ± SD of 24-h blood glucose levels, mean amplitude of glycemic excursions and postprandial hyperglycemic spikes. Arterial structure and function was measured as carotid IMT and stiffness. MAJOR
FINDINGS: The different approaches to assessing blood glucose variability well correlated between and with HbA1c. Carotid IMT and stiffness showed significant correlations with age, blood pressure, heart rate and daily insulin intake but a non- significant correlation with blood glucose variability. PRINCIPAL
CONCLUSION: Thus, in type 1 diabetes mellitus, measures of glycemic variability are useful in predicting both actual and long-lasting glycemic control. In absence of diabetes-related complications and of any intima-media thickness alterations, the major predictors of arterial distensibility are represented by traditional risk factors beside glycemic 24-h control.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23862738     DOI: 10.3109/08037051.2013.791413

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  5 in total

1.  Glycemic variability predicts inflammation in adolescents with type 1 diabetes.

Authors:  Robert P Hoffman; Amanda S Dye; Hong Huang; John A Bauer
Journal:  J Pediatr Endocrinol Metab       Date:  2016-10-01       Impact factor: 1.634

2.  Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study.

Authors:  Chrisandra Shufelt; Omeed Elboudwarej; B Delia Johnson; Puja Mehta; Vera Bittner; Glenn Braunstein; Sarah Berga; Frank Stanczyk; Kathleen Dwyer; C Noel Bairey Merz
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

3.  Analysis of risk factors for carotid intima-media thickness in patients with type 2 diabetes mellitus in Western China assessed by logistic regression combined with a decision tree model.

Authors:  Yuan-Yuan Zhou; Hong-Mei Qiu; Ying Yang; Yuan-Yuan Han
Journal:  Diabetol Metab Syndr       Date:  2020-01-28       Impact factor: 3.320

4.  Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes.

Authors:  Naoto Katakami; Tomoya Mita; Naohiro Taya; Yosuke Okada; Satomi Wakasugi; Hidenori Yoshii; Toshihiko Shiraiwa; Akihito Otsuka; Yutaka Umayahara; Kayoko Ryomoto; Masahiro Hatazaki; Tetsuyuki Yasuda; Tsunehiko Yamamoto; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada
Journal:  Cardiovasc Diabetol       Date:  2021-05-04       Impact factor: 9.951

Review 5.  Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.

Authors:  Michael Yapanis; Steven James; Maria E Craig; David O'Neal; Elif I Ekinci
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.